|

CYTALUX™ (pafolacianine) injection preoperatively Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • John Waters1

Indications

  • Gynecologic Cancers1
  • Gastrointestinal Cancers1
  • Esophageal Cancer1
  • Cancer1

Dallas, Texas1 trial

Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.

Clemments University Hospital

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.